NTHI — NEONC TECHNOLOGIES HOLDINGS, INC.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1979414 ·
Last close
$3.16
Market Cap
$91.03M
52W High
$12.99
52W Low
$2.95
ADV30
208,515
Next earnings
2026-11-12
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 0 | — | -13,587,109 | -14,240,044 | 5,231,792 | 1,973,420 | 23,761,103 |
| Mar 2026 | 0 | — | -7,008,539 | -8,819,932 | 3,330,161 | 138,601 | 16,561,326 |
| Dec 2025 | 0 | — | -13,625,675 | -15,524,104 | 2,823,634 | 58,729 | 20,331,363 |
| Sep 2025 | 0 | — | -6,934,647 | -8,615,920 | 4,082,916 | 1,513,224 | 15,897,186 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-21,705,667
Investing CF
—
Financing CF
$16,905,056
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-2.91
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-121,574,587
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-35,461,857
Pretax Income TTM
$-38,640,126
Interest Exp TTM
$3,178,269
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$39,990
EBITDA
—
Free Cash Flow
$5,401,299
Enterprise Value
$92,961,904
Total Cash
$1,973,420
Total Debt
$328,217
Shares Out
28,805,380
Trailing EPS
$-2.12
Book Value
$-0.87
ROE
—
ROA
-635.0%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 39,990 | -58,169,198 | -62,146,210 | 2,823,634 | 20,331,363 | -17,507,729 | -20,363,948 |
| Dec 2024 | 83,000 | -7,142,522 | -11,898,464 | 3,417,241 | 8,922,202 | -5,504,961 | -4,213,916 |
| Dec 2023 | 70,462 | -8,097,669 | -14,921,065 | 1,265,376 | 15,253,629 | -13,988,253 | -1,880,012 |
| Dec 2022 | 20,000 | -2,837,604 | -3,046,757 | 728,682 | 2,304,093 | -1,575,411 | -881,736 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-1.01
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| RLYB | Rallybio Corp | $90.54M | $17.05 | — |
| RANI | Rani Therapeutics Holdings, Inc. | $89.57M | $0.78 | — |
| BGM | BGM Group Ltd. | $92.87M | $0.24 | — |
| BMEA | Biomea Fusion, Inc. | $93.27M | $1.29 | — |
| ACRV | Acrivon Therapeutics, Inc. | $88.28M | $2.06 | — |
News headlines (Yahoo Finance, 1h cache)
NeOnc Technologies Announces FDA End of Phase 1 Meeting for NEO212
2026-09-28 13:59 · Yahoo
NeOnc Technologies Redeems All Outstanding Series A Convertible Preferred Stock and Eliminates Related Potential Dilution
2026-09-17 13:10 · Yahoo
NeOnc Executives Invest Approximately $629,000 in Open-Market Stock Purchases Following Positive NEO100 Phase 2a Results
2026-09-16 12:58 · Yahoo
NeOnc Technologies Holdings, Inc. Announces Pricing of $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules with New and Existing Institutional Investors
2026-09-09 13:27 · Yahoo
NeOnc Technologies Holdings Inc (NTHI) (Q2 2026) Earnings Call Highlights: First Annual Meeting ...
2026-08-17 17:31 · Yahoo
Stonegate Capital Partners Updates Coverage on NeOnc Technologies Holdings, Inc. (NTHI) 2Q26
2026-08-13 20:18 · Yahoo
NeOnc Technologies shares jump after positive Phase 2a glioma results
2026-08-12 13:39 · Yahoo
NeOnc Technologies to Host Investor Conference Call to Discuss Topline Phase 2a Results for Intranasal NEO100 in Recurrent IDH1-Mutant High-Grade Glioma
2026-08-10 13:42 · Yahoo
NeOnc Technologies Appoints Strategy and Finance Executive Nasim Shomali to its Board of Directors
2026-07-27 14:37 · Yahoo
NeOnc Receives FDA Written Feedback on NEO212 CMC Development and Capsule-to-Tablet Transition
2026-07-15 13:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.